Also trades as: NLH.V (TSXV) · $vol 0M
NVLPF OTC
Nova Leap Health Corp.
1W: -0.5%
1M: -13.0%
3M: +48.2%
YTD: +74.0%
1Y: +49.1%
3Y: +127.7%
5Y: -51.3%
$0.37
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$32M
+24.3% ▲
5Y CAGR: +13.1%
Gross Profit
$12M
+19.9% ▲
5Y CAGR: +15.1%
Operating Income
$1M
+30.3% ▲
Net Income
-$193K
-114.0% ▼
EPS (Diluted)
$-0.00
-113.9% ▼
EBITDA
$2M
+72.8% ▲
5Y CAGR: +11.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $21M | $28M | $26M | $26M | $32M |
| YoY Growth | +22.9% | +32.5% | -7.2% | -1.6% | +24.3% |
| Cost of Revenue | $14M | $18M | $16M | $16M | $20M |
| Gross Profit | $7M | $10M | $10M | $10M | $12M |
| Gross Margin | 33.9% | 35.4% | 37.3% | 38.4% | 37.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8M | $10M | $8M | $8M | $11M |
| Operating Expenses | $3M | $11M | $9M | $9M | $11M |
| Operating Income | -$1M | -$1M | $460K | $864K | $1M |
| Operating Margin | -5.8% | -3.8% | 1.8% | 3.4% | 3.5% |
| Interest Expense | $401K | $271K | $145K | $107K | $356K |
| Income Before Tax | $2M | -$1M | -$1M | $2M | -$134K |
| Tax Expense | $713K | -$371K | -$311K | $434K | $59K |
| Net Income | $2M | -$836K | -$1M | $1M | -$193K |
| Net Margin | 8.3% | -3.0% | -4.0% | 5.4% | -0.6% |
| EPS (Diluted) | $0.02 | $-0.01 | $-0.01 | $0.02 | $-0.00 |
| EBITDA | $4M | $367K | -$336K | $1M | $2M |
| Shares Outstanding | 78M | 81M | 86M | 87M | 87M |